Journal of Pharmacy And Bioallied Sciences : Table of Contents

	Login \| Users Online: 1124
	Home \| About us \| Editorial board \| Search \| Ahead of print \| Current Issue \| Past Issues \| Instructions \| Online submission

Article Cited by others

ORIGINAL ARTICLE

Subcutaneous implants for long-acting drug therapy in laboratory animals may generate unintended drug reservoirs

Guarnieri Michael, Tyler Betty M, DeTolla Louis, Zhao Ming, Kobrin Barry

Year : 2014| Volume: 6| Issue : 1 | Page no: 38-42

This article has been cited by

1	Probuphine® (buprenorphine implant): a promising candidate in opioid dependence

	Preeti Barnwal,Saibal Das,Somnath Mondal,Anand Ramasamy,Tanay Maiti,Arunava Saha

	Therapeutic Advances in Psychopharmacology. 2017; 7(3): 119

	[Pubmed] [Google Scholar] [DOI]

2	Evaluation of buprenorphine hydrochloride Pluronic® gel formulation in male C57BL/6NCrl mice

	Terry L. Blankenship-Paris,John W. Dutton,David R. Goulding,Christopher A. McGee,Grace E. Kissling,Page H. Myers

	Lab Animal. 2016; 45(10): 370

	[Pubmed] [Google Scholar] [DOI]

3	Subcutaneous Implants of Buprenorphine-Cholesterol-Triglyceride Powder in Mice

	L. DeTolla,R. Sanchez,E. Khan,B. Tyler,M. Guarnieri

	Journal of Veterinary Medicine. 2014; 2014: 1

	[Pubmed] [Google Scholar] [DOI]